EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Selective CB2 Agonist JWH-133 Suppresses Viability and Migration-Related Responses in Prostate Cancer Cells

Seda Sabah Özcan, Rehime Yapar iD, İsmail Değerli iD, Levent Elmas, Mehmet Korkmaz, Murat Çakır iD

Pharmaceuticals · 19.07.2026 · 19 (7) · 1114

DOI: 10.3390/ph19071114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 19.07.2026. Verfasst von Seda Sabah Özcan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Manisa Celal Bayar University, Manisa 4500, Türkiye. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Department of Scientific Research Projects, Yozgat Bozok University Scientific Research Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Cannabinoid receptor type 2 (CB2) agonists have attracted attention because of their potential effects on tumor-related cellular processes in different cancer models. In the present study, we investigated the effects of the selective CB2 agonist JWH-133 on prostate cancer cell lines (LNCaP, DU-145, and PC3).

Methods

Cell viability was evaluated using the MTT assay, while colony-forming capacity and migration-related responses were assessed by colony formation and wound-healing assays, respectively. In addition, the expression levels of selected cell-cycle- and apoptosis-related genes were analyzed by quantitative real-time PCR.

Results

JWH-133 reduced cell viability in a time- and concentration-dependent manner, although the magnitude of this effect differed among prostate cancer cell lines. The compound also reduced colony formation in PC3 and LNCaP cells and decreased wound closure in PC3 cells under the experimental conditions used. Furthermore, JWH-133 altered the expression of several cell-cycle- and apoptosis-related genes in DU-145 and PC3 cells.

Conclusions

Overall, these findings suggest that JWH-133 modulates multiple cellular responses in prostate cancer cells in a cell-line-dependent manner. However, additional mechanistic studies are required to clarify the molecular pathways underlying these effects.

Schlagwörter

Stichwörter der Autor:innen

JWH-133UN SDG 3: Good Health and Wellcannabinoid receptor type 2cell viabilitymigrationprostate cancer

Autor:innen und Institutionen

  • Department of Medical Biology, Faculty of Medicine, Manisa Celal Bayar University, Manisa 4500, Türkiye.
  • Department of Medical Biology, Faculty of Medicine, İzmir Bakırçay University, Izmir 35660, Türkiye.
  • Department of Physiology, Faculty of Medicine, Yozgat Bozok University, Yozgat 66200, Türkiye.

ORCID-Profile: Rehime Yapar, İsmail Değerli, Murat Çakır

Förderung

  • the Department of Scientific Research Projects
  • Yozgat Bozok University Scientific Research Projects

Zitieren

APA

Özcan, S. S., Yapar, R., Değerli, İ., Elmas, L., Korkmaz, M., & Çakır, M. (2026). Selective CB2 Agonist JWH-133 Suppresses Viability and Migration-Related Responses in Prostate Cancer Cells. Pharmaceuticals, 19(7), 1114. https://doi.org/10.3390/ph19071114

Vancouver

Özcan SS, Yapar R, Değerli İ, Elmas L, Korkmaz M, Çakır M. Selective CB2 Agonist JWH-133 Suppresses Viability and Migration-Related Responses in Prostate Cancer Cells. Pharmaceuticals. 2026;19(7):1114. doi:10.3390/ph19071114

BibTeX
@article{zcan2026,
  author = {Özcan, Seda Sabah and Yapar, Rehime and Değerli, İsmail and Elmas, Levent and Korkmaz, Mehmet and Çakır, Murat},
  title = {Selective CB2 Agonist JWH-133 Suppresses Viability and Migration-Related Responses in Prostate Cancer Cells},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {7},
  pages = {1114},
  doi = {10.3390/ph19071114}
}
Kostenlos starten →